Consolidation of AML Therapy with Autograft and Allograft Procedures Does not Negate the Poor Prognostic Impact of FLT-3 Internal Tandem Duplications: Results for UK MRC AML 10 and 12 Trials.

Reviewer: Julie Draznin Maltzman, MD
Ultima Vez Modificado: 9 de diciembre del 2002

Translation for this article does not exist


Catherine and Finn
by OncoLink Editorial Team
December 01, 2015